SCN9A under Phase 2 in Australia, the Company is Olipass, does anyone reckon this could be competition?
OliPass Peptide Nucleic Acid (OliPass PNA) was derived from PNA by rationally introducing cationic lipid moiety onto nucleobase. By covalently attaching such cationic lipid groups onto PNA, the cell permeability markedly improved. In addition, the affinity for RNA increased by at least a million times.
SCN9A non-opioid painkiller
-
- There are more pages in this discussion • 87 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.3¢ |
Change
-0.003(0.82%) |
Mkt cap ! $121.2M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 31.0¢ | 30.0¢ | $41.35K | 134.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 235647 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 25996 | 3 |
View Market Depth
| Last trade - 10.59am 22/08/2025 (20 minute delay) ? |
| PAR (ASX) Chart |